Click for best price
Parkinsons Disease Drugs Market Size, Share 2022
Market Analysis and Insights: Global Parkinsons Disease Drugs Market
The global Parkinsons Disease Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Parkinsons Disease Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Parkinsons Disease Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Parkinsons Disease Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Parkinsons Disease Drugs market.
Global Parkinsons Disease Drugs Scope and Market Size
Parkinsons Disease Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Parkinsons Disease Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Clinical
Experiment
Segment by Application
Treament
Prevention
By Company
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Parkinsons Disease Drugs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Parkinsons Disease Drugs, with price, sales, revenue, and global market share of Parkinsons Disease Drugs from 2019 to 2022.
Chapter 3, the Parkinsons Disease Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Parkinsons Disease Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Parkinsons Disease Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Parkinsons Disease Drugs.
Chapter 13, 14, and 15, to describe Parkinsons Disease Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Parkinsons Disease Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Parkinsons Disease Drugs Market Insights, Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
111 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Parkinsons Disease Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Parkinsons Disease Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Clinical
1.2.3 Experiment
1.3 Market by Application
1.3.1 Global Parkinsons Disease Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Treament
1.3.3 Prevention
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Parkinsons Disease Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Parkinsons Disease Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Parkinsons Disease Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Parkinsons Disease Drugs Sales by Region
2.4.1 Global Parkinsons Disease Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Parkinsons Disease Drugs by Region (2023-2028)
2.5 Global Parkinsons Disease Drugs Revenue by Region
2.5.1 Global Parkinsons Disease Drugs Revenue by Region (2017-2022)
2.5.2 Global Parkinsons Disease Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Parkinsons Disease Drugs Sales by Manufacturers
3.1.1 Global Top Parkinsons Disease Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Parkinsons Disease Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Parkinsons Disease Drugs in 2021
3.2 Global Parkinsons Disease Drugs Revenue by Manufacturers
3.2.1 Global Parkinsons Disease Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Parkinsons Disease Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Parkinsons Disease Drugs Revenue in 2021
3.3 Global Parkinsons Disease Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Parkinsons Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Parkinsons Disease Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Parkinsons Disease Drugs Sales by Type
4.1.1 Global Parkinsons Disease Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Parkinsons Disease Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Parkinsons Disease Drugs Sales Market Share by Type (2017-2028)
4.2 Global Parkinsons Disease Drugs Revenue by Type
4.2.1 Global Parkinsons Disease Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Parkinsons Disease Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Parkinsons Disease Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Parkinsons Disease Drugs Price by Type
4.3.1 Global Parkinsons Disease Drugs Price by Type (2017-2022)
4.3.2 Global Parkinsons Disease Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Parkinsons Disease Drugs Sales by Application
5.1.1 Global Parkinsons Disease Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Parkinsons Disease Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Parkinsons Disease Drugs Sales Market Share by Application (2017-2028)
5.2 Global Parkinsons Disease Drugs Revenue by Application
5.2.1 Global Parkinsons Disease Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Parkinsons Disease Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Parkinsons Disease Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Parkinsons Disease Drugs Price by Application
5.3.1 Global Parkinsons Disease Drugs Price by Application (2017-2022)
5.3.2 Global Parkinsons Disease Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Parkinsons Disease Drugs Market Size by Type
6.1.1 North America Parkinsons Disease Drugs Sales by Type (2017-2028)
6.1.2 North America Parkinsons Disease Drugs Revenue by Type (2017-2028)
6.2 North America Parkinsons Disease Drugs Market Size by Application
6.2.1 North America Parkinsons Disease Drugs Sales by Application (2017-2028)
6.2.2 North America Parkinsons Disease Drugs Revenue by Application (2017-2028)
6.3 North America Parkinsons Disease Drugs Market Size by Country
6.3.1 North America Parkinsons Disease Drugs Sales by Country (2017-2028)
6.3.2 North America Parkinsons Disease Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Parkinsons Disease Drugs Market Size by Type
7.1.1 Europe Parkinsons Disease Drugs Sales by Type (2017-2028)
7.1.2 Europe Parkinsons Disease Drugs Revenue by Type (2017-2028)
7.2 Europe Parkinsons Disease Drugs Market Size by Application
7.2.1 Europe Parkinsons Disease Drugs Sales by Application (2017-2028)
7.2.2 Europe Parkinsons Disease Drugs Revenue by Application (2017-2028)
7.3 Europe Parkinsons Disease Drugs Market Size by Country
7.3.1 Europe Parkinsons Disease Drugs Sales by Country (2017-2028)
7.3.2 Europe Parkinsons Disease Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Parkinsons Disease Drugs Market Size by Type
8.1.1 Asia Pacific Parkinsons Disease Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Parkinsons Disease Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Parkinsons Disease Drugs Market Size by Application
8.2.1 Asia Pacific Parkinsons Disease Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Parkinsons Disease Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Parkinsons Disease Drugs Market Size by Region
8.3.1 Asia Pacific Parkinsons Disease Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Parkinsons Disease Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Parkinsons Disease Drugs Market Size by Type
9.1.1 Latin America Parkinsons Disease Drugs Sales by Type (2017-2028)
9.1.2 Latin America Parkinsons Disease Drugs Revenue by Type (2017-2028)
9.2 Latin America Parkinsons Disease Drugs Market Size by Application
9.2.1 Latin America Parkinsons Disease Drugs Sales by Application (2017-2028)
9.2.2 Latin America Parkinsons Disease Drugs Revenue by Application (2017-2028)
9.3 Latin America Parkinsons Disease Drugs Market Size by Country
9.3.1 Latin America Parkinsons Disease Drugs Sales by Country (2017-2028)
9.3.2 Latin America Parkinsons Disease Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Parkinsons Disease Drugs Market Size by Type
10.1.1 Middle East and Africa Parkinsons Disease Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Parkinsons Disease Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Parkinsons Disease Drugs Market Size by Application
10.2.1 Middle East and Africa Parkinsons Disease Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Parkinsons Disease Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Parkinsons Disease Drugs Market Size by Country
10.3.1 Middle East and Africa Parkinsons Disease Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Parkinsons Disease Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Overview
11.1.3 Johnson & Johnson Parkinsons Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Johnson & Johnson Parkinsons Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Johnson & Johnson Recent Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Corporation Information
11.2.2 Gilead Sciences Overview
11.2.3 Gilead Sciences Parkinsons Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Gilead Sciences Parkinsons Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Gilead Sciences Recent Developments
11.3 Pacira
11.3.1 Pacira Corporation Information
11.3.2 Pacira Overview
11.3.3 Pacira Parkinsons Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Pacira Parkinsons Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pacira Recent Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Corporation Information
11.4.2 Sun Pharmaceutical Overview
11.4.3 Sun Pharmaceutical Parkinsons Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sun Pharmaceutical Parkinsons Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sun Pharmaceutical Recent Developments
11.5 Luye Pharma
11.5.1 Luye Pharma Corporation Information
11.5.2 Luye Pharma Overview
11.5.3 Luye Pharma Parkinsons Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Luye Pharma Parkinsons Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Luye Pharma Recent Developments
11.6 Sigma-Tau Group
11.6.1 Sigma-Tau Group Corporation Information
11.6.2 Sigma-Tau Group Overview
11.6.3 Sigma-Tau Group Parkinsons Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Sigma-Tau Group Parkinsons Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sigma-Tau Group Recent Developments
11.7 Fudan-Zhangjiang
11.7.1 Fudan-Zhangjiang Corporation Information
11.7.2 Fudan-Zhangjiang Overview
11.7.3 Fudan-Zhangjiang Parkinsons Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Fudan-Zhangjiang Parkinsons Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Fudan-Zhangjiang Recent Developments
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Corporation Information
11.8.2 Teva Pharmaceutical Overview
11.8.3 Teva Pharmaceutical Parkinsons Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Teva Pharmaceutical Parkinsons Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Teva Pharmaceutical Recent Developments
11.9 CSPC
11.9.1 CSPC Corporation Information
11.9.2 CSPC Overview
11.9.3 CSPC Parkinsons Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 CSPC Parkinsons Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 CSPC Recent Developments
11.10 Novartis
11.10.1 Novartis Corporation Information
11.10.2 Novartis Overview
11.10.3 Novartis Parkinsons Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Novartis Parkinsons Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novartis Recent Developments
11.11 Kingond Pharm
11.11.1 Kingond Pharm Corporation Information
11.11.2 Kingond Pharm Overview
11.11.3 Kingond Pharm Parkinsons Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Kingond Pharm Parkinsons Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Kingond Pharm Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Parkinsons Disease Drugs Industry Chain Analysis
12.2 Parkinsons Disease Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Parkinsons Disease Drugs Production Mode & Process
12.4 Parkinsons Disease Drugs Sales and Marketing
12.4.1 Parkinsons Disease Drugs Sales Channels
12.4.2 Parkinsons Disease Drugs Distributors
12.5 Parkinsons Disease Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Parkinsons Disease Drugs Industry Trends
13.2 Parkinsons Disease Drugs Market Drivers
13.3 Parkinsons Disease Drugs Market Challenges
13.4 Parkinsons Disease Drugs Market Restraints
14 Key Findings in The Global Parkinsons Disease Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Parkinsons Disease Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Clinical
Table 3. Major Manufacturers of Experiment
Table 4. Global Parkinsons Disease Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Parkinsons Disease Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Parkinsons Disease Drugs Sales by Region (2017-2022) & (K Units)
Table 7. Global Parkinsons Disease Drugs Sales Market Share by Region (2017-2022)
Table 8. Global Parkinsons Disease Drugs Sales by Region (2023-2028) & (K Units)
Table 9. Global Parkinsons Disease Drugs Sales Market Share by Region (2023-2028)
Table 10. Global Parkinsons Disease Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Parkinsons Disease Drugs Revenue Market Share by Region (2017-2022)
Table 12. Global Parkinsons Disease Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Parkinsons Disease Drugs Revenue Market Share by Region (2023-2028)
Table 14. Global Parkinsons Disease Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Parkinsons Disease Drugs Sales Share by Manufacturers (2017-2022)
Table 16. Global Parkinsons Disease Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Parkinsons Disease Drugs Revenue Share by Manufacturers (2017-2022)
Table 18. Parkinsons Disease Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
Table 19. Global Parkinsons Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Parkinsons Disease Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinsons Disease Drugs as of 2021)
Table 21. Parkinsons Disease Drugs Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Parkinsons Disease Drugs Product Offered
Table 23. Date of Manufacturers Enter into Parkinsons Disease Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Parkinsons Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 26. Global Parkinsons Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 27. Global Parkinsons Disease Drugs Sales Share by Type (2017-2022)
Table 28. Global Parkinsons Disease Drugs Sales Share by Type (2023-2028)
Table 29. Global Parkinsons Disease Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Parkinsons Disease Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Parkinsons Disease Drugs Revenue Share by Type (2017-2022)
Table 32. Global Parkinsons Disease Drugs Revenue Share by Type (2023-2028)
Table 33. Parkinsons Disease Drugs Price by Type (2017-2022) & (USD/Unit)
Table 34. Global Parkinsons Disease Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
Table 35. Global Parkinsons Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 36. Global Parkinsons Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 37. Global Parkinsons Disease Drugs Sales Share by Application (2017-2022)
Table 38. Global Parkinsons Disease Drugs Sales Share by Application (2023-2028)
Table 39. Global Parkinsons Disease Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Parkinsons Disease Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Parkinsons Disease Drugs Revenue Share by Application (2017-2022)
Table 42. Global Parkinsons Disease Drugs Revenue Share by Application (2023-2028)
Table 43. Parkinsons Disease Drugs Price by Application (2017-2022) & (USD/Unit)
Table 44. Global Parkinsons Disease Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
Table 45. North America Parkinsons Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 46. North America Parkinsons Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 47. North America Parkinsons Disease Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Parkinsons Disease Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Parkinsons Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 50. North America Parkinsons Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 51. North America Parkinsons Disease Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Parkinsons Disease Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Parkinsons Disease Drugs Sales by Country (2017-2022) & (K Units)
Table 54. North America Parkinsons Disease Drugs Sales by Country (2023-2028) & (K Units)
Table 55. North America Parkinsons Disease Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Parkinsons Disease Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Parkinsons Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 58. Europe Parkinsons Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 59. Europe Parkinsons Disease Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Parkinsons Disease Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Parkinsons Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 62. Europe Parkinsons Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 63. Europe Parkinsons Disease Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Parkinsons Disease Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Parkinsons Disease Drugs Sales by Country (2017-2022) & (K Units)
Table 66. Europe Parkinsons Disease Drugs Sales by Country (2023-2028) & (K Units)
Table 67. Europe Parkinsons Disease Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Parkinsons Disease Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Parkinsons Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Parkinsons Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Parkinsons Disease Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Parkinsons Disease Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Parkinsons Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Parkinsons Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Parkinsons Disease Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Parkinsons Disease Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Parkinsons Disease Drugs Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Parkinsons Disease Drugs Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Parkinsons Disease Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Parkinsons Disease Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Parkinsons Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Parkinsons Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Parkinsons Disease Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Parkinsons Disease Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Parkinsons Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Parkinsons Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Parkinsons Disease Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Parkinsons Disease Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Parkinsons Disease Drugs Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Parkinsons Disease Drugs Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Parkinsons Disease Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Parkinsons Disease Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Parkinsons Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Parkinsons Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Parkinsons Disease Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Parkinsons Disease Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Parkinsons Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Parkinsons Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Parkinsons Disease Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Parkinsons Disease Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Parkinsons Disease Drugs Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Parkinsons Disease Drugs Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Parkinsons Disease Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Parkinsons Disease Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 105. Johnson & Johnson Corporation Information
Table 106. Johnson & Johnson Description and Major Businesses
Table 107. Johnson & Johnson Parkinsons Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 108. Johnson & Johnson Parkinsons Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Johnson & Johnson Recent Developments
Table 110. Gilead Sciences Corporation Information
Table 111. Gilead Sciences Description and Major Businesses
Table 112. Gilead Sciences Parkinsons Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 113. Gilead Sciences Parkinsons Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Gilead Sciences Recent Developments
Table 115. Pacira Corporation Information
Table 116. Pacira Description and Major Businesses
Table 117. Pacira Parkinsons Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. Pacira Parkinsons Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Pacira Recent Developments
Table 120. Sun Pharmaceutical Corporation Information
Table 121. Sun Pharmaceutical Description and Major Businesses
Table 122. Sun Pharmaceutical Parkinsons Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. Sun Pharmaceutical Parkinsons Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Sun Pharmaceutical Recent Developments
Table 125. Luye Pharma Corporation Information
Table 126. Luye Pharma Description and Major Businesses
Table 127. Luye Pharma Parkinsons Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 128. Luye Pharma Parkinsons Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Luye Pharma Recent Developments
Table 130. Sigma-Tau Group Corporation Information
Table 131. Sigma-Tau Group Description and Major Businesses
Table 132. Sigma-Tau Group Parkinsons Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 133. Sigma-Tau Group Parkinsons Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Sigma-Tau Group Recent Developments
Table 135. Fudan-Zhangjiang Corporation Information
Table 136. Fudan-Zhangjiang Description and Major Businesses
Table 137. Fudan-Zhangjiang Parkinsons Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 138. Fudan-Zhangjiang Parkinsons Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Fudan-Zhangjiang Recent Developments
Table 140. Teva Pharmaceutical Corporation Information
Table 141. Teva Pharmaceutical Description and Major Businesses
Table 142. Teva Pharmaceutical Parkinsons Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 143. Teva Pharmaceutical Parkinsons Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Teva Pharmaceutical Recent Developments
Table 145. CSPC Corporation Information
Table 146. CSPC Description and Major Businesses
Table 147. CSPC Parkinsons Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 148. CSPC Parkinsons Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. CSPC Recent Developments
Table 150. Novartis Corporation Information
Table 151. Novartis Description and Major Businesses
Table 152. Novartis Parkinsons Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 153. Novartis Parkinsons Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Novartis Recent Developments
Table 155. Kingond Pharm Corporation Information
Table 156. Kingond Pharm Description and Major Businesses
Table 157. Kingond Pharm Parkinsons Disease Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 158. Kingond Pharm Parkinsons Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Kingond Pharm Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Parkinsons Disease Drugs Distributors List
Table 163. Parkinsons Disease Drugs Customers List
Table 164. Parkinsons Disease Drugs Market Trends
Table 165. Parkinsons Disease Drugs Market Drivers
Table 166. Parkinsons Disease Drugs Market Challenges
Table 167. Parkinsons Disease Drugs Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Parkinsons Disease Drugs Product Picture
Figure 3. Global Parkinsons Disease Drugs Market Share by Type in 2021 & 2028
Figure 3. Clinical Product Picture
Figure 4. Experiment Product Picture
Figure 5. Global Parkinsons Disease Drugs Market Share by Application in 2021 & 2028
Figure 6. Treament
Figure 7. Prevention
Figure 8. Parkinsons Disease Drugs Report Years Considered
Figure 9. Global Parkinsons Disease Drugs Sales 2017-2028 (K Units)
Figure 10. Global Parkinsons Disease Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Parkinsons Disease Drugs Revenue 2017-2028 (US$ Million)
Figure 12. Global Parkinsons Disease Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Parkinsons Disease Drugs Sales Market Share by Region (2017-2022)
Figure 14. Global Parkinsons Disease Drugs Sales Market Share by Region (2023-2028)
Figure 15. North America Parkinsons Disease Drugs Sales YoY (2017-2028) & (K Units)
Figure 16. North America Parkinsons Disease Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Parkinsons Disease Drugs Sales YoY (2017-2028) & (K Units)
Figure 18. Europe Parkinsons Disease Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Parkinsons Disease Drugs Sales YoY (2017-2028) & (K Units)
Figure 20. Asia-Pacific Parkinsons Disease Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Parkinsons Disease Drugs Sales YoY (2017-2028) & (K Units)
Figure 22. Latin America Parkinsons Disease Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Parkinsons Disease Drugs Sales YoY (2017-2028) & (K Units)
Figure 24. Middle East & Africa Parkinsons Disease Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Parkinsons Disease Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Parkinsons Disease Drugs in the World: Market Share by Parkinsons Disease Drugs Revenue in 2021
Figure 27. Global Parkinsons Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Parkinsons Disease Drugs Sales Market Share by Type (2017-2028)
Figure 29. Global Parkinsons Disease Drugs Revenue Market Share by Type (2017-2028)
Figure 30. Global Parkinsons Disease Drugs Sales Market Share by Application (2017-2028)
Figure 31. Global Parkinsons Disease Drugs Revenue Market Share by Application (2017-2028)
Figure 32. North America Parkinsons Disease Drugs Sales Market Share by Type (2017-2028)
Figure 33. North America Parkinsons Disease Drugs Revenue Market Share by Type (2017-2028)
Figure 34. North America Parkinsons Disease Drugs Sales Market Share by Application (2017-2028)
Figure 35. North America Parkinsons Disease Drugs Revenue Market Share by Application (2017-2028)
Figure 36. North America Parkinsons Disease Drugs Sales Share by Country (2017-2028)
Figure 37. North America Parkinsons Disease Drugs Revenue Share by Country (2017-2028)
Figure 38. U.S. Parkinsons Disease Drugs Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Parkinsons Disease Drugs Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Parkinsons Disease Drugs Sales Market Share by Type (2017-2028)
Figure 41. Europe Parkinsons Disease Drugs Revenue Market Share by Type (2017-2028)
Figure 42. Europe Parkinsons Disease Drugs Sales Market Share by Application (2017-2028)
Figure 43. Europe Parkinsons Disease Drugs Revenue Market Share by Application (2017-2028)
Figure 44. Europe Parkinsons Disease Drugs Sales Share by Country (2017-2028)
Figure 45. Europe Parkinsons Disease Drugs Revenue Share by Country (2017-2028)
Figure 46. Germany Parkinsons Disease Drugs Revenue (2017-2028) & (US$ Million)
Figure 47. France Parkinsons Disease Drugs Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Parkinsons Disease Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Parkinsons Disease Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Parkinsons Disease Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Parkinsons Disease Drugs Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Parkinsons Disease Drugs Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Parkinsons Disease Drugs Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Parkinsons Disease Drugs Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Parkinsons Disease Drugs Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Parkinsons Disease Drugs Revenue Share by Region (2017-2028)
Figure 57. China Parkinsons Disease Drugs Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Parkinsons Disease Drugs Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Parkinsons Disease Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. India Parkinsons Disease Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Parkinsons Disease Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. Taiwan Parkinsons Disease Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Parkinsons Disease Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Parkinsons Disease Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Parkinsons Disease Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Philippines Parkinsons Disease Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Parkinsons Disease Drugs Sales Market Share by Type (2017-2028)
Figure 68. Latin America Parkinsons Disease Drugs Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Parkinsons Disease Drugs Sales Market Share by Application (2017-2028)
Figure 70. Latin America Parkinsons Disease Drugs Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Parkinsons Disease Drugs Sales Share by Country (2017-2028)
Figure 72. Latin America Parkinsons Disease Drugs Revenue Share by Country (2017-2028)
Figure 73. Mexico Parkinsons Disease Drugs Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Parkinsons Disease Drugs Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Parkinsons Disease Drugs Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Parkinsons Disease Drugs Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Parkinsons Disease Drugs Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Parkinsons Disease Drugs Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Parkinsons Disease Drugs Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Parkinsons Disease Drugs Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Parkinsons Disease Drugs Revenue Share by Country (2017-2028)
Figure 82. Turkey Parkinsons Disease Drugs Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Parkinsons Disease Drugs Revenue (2017-2028) & (US$ Million)
Figure 84. U.A.E Parkinsons Disease Drugs Revenue (2017-2028) & (US$ Million)
Figure 85. Parkinsons Disease Drugs Value Chain
Figure 86. Parkinsons Disease Drugs Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
